Earnings Call · Q3 FY2021·2021-11-16

Q3 21EPS -6.67%·Rev n/aQ2 21EPS -34.26%·Rev n/aQ1 21EPS -71.43%·Rev n/aQ4 20EPS -98.61%·Rev n/a⚠ consensus missing

Mirum Pharmaceuticals, Inc. MIRM

Ian Clements — Chief Financial Officer

Chris Peetz — President and CEO

Peter Radovich — Chief Operating Officer

Pamela Vig — Head of Research and Development

+2.6%1d on move date+2.2% vs SPY3d+0.4%5d−9.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MIRM calls or request research access.

More MIRM calls Browse calls Request research access